This inventor holds 81 USPTO granted patents and 14 published patent applications and 10 EPO patents, primarily in Endovascular Devices (CPC class A61B). Top assignees: Bridgepoint Medical, Inc., Boston Scientific Scimed, Inc., Cyberonics, Inc.. Active years: 2002-2026.
Inventors with similar research interests:
Location History:
- Falcon Heights, MN (US) (2002 - 2004)
- Stillwater, MN (US) (2004 - 2011)
- Elmo, MN (US) (2020)
- White Bear Lake, MN (US) (2006 - 2022)
- Lake Elmo, MN (US) (2015 - 2023)
Company Filing History:
22 out of 37 
10 out of 6,576 
10 out of 257 
Years Active: 2002-2026
Areas of Expertise:
Title: Robert E Atkinson: Innovating Endovascular Treatment Methods
Introduction:
Robert E Atkinson, a prolific inventor and innovator based in White Bear Lake, MN, has made significant contributions to the field of endovascular medicine. Known for his expertise in developing devices and methods for treating chronic total occlusions, Atkinson is a valued figure in the medical innovation community. With a strong track record of 71 patents to his name, Atkinson's latest inventions continue to push the boundaries of medical treatment.
Latest Patents:
Atkinson's recent patents focus on endovascular devices and methods for the treatment of chronic total occlusions. These patents address the challenge of treating blockages in blood vessels, a condition that can lead to serious health complications. By developing novel intravascular devices and techniques, Atkinson aims to facilitate effective treatment and improve patient outcomes.
One of the disclosed embodiments involves a method of treating chronic total occlusions by inserting an intravascular device with a distal portion containing a side port into the vascular lumen. This device allows for precise positioning within the vascular wall and enables lateral movement for improved accessibility to the occlusion site.
Career Highlights:
Throughout his career, Robert E Atkinson has distinguished himself as a leading innovator in the field of endovascular medicine. He has demonstrated a deep understanding of the complexities involved in treating chronic total occlusions and has dedicated his efforts to developing advanced solutions.
Collaborations:
Atkinson's work with various companies has played a vital role in bringing his innovations to life. Noteworthy collaborations include his contributions to Bridgepoint Medical, Inc., a company renowned for its expertise in interventional cardiology and endovascular therapy. Atkinson's partnership with Bridgepoint Medical, Inc. has provided a platform for his ideas to be transformed into tangible medical advancements.
In addition, Atkinson has also collaborated with Cyberonics, Inc., a prominent medical technology company specializing in neuromodulation devices. These collaborations with industry leaders showcase Atkinson's ability to work alongside talented professionals to leverage their expertise and bring his innovations to fruition.
Conclusion:
Robert E Atkinson's numerous patents and his dedication to the field of endovascular medicine highlight his commitment to improving patient outcomes. Through his innovative inventions and collaborations with industry leaders, he has made significant contributions to the treatment of chronic total occlusions. As Atkinson continues his work, we can expect further advancements that push the boundaries of medical innovation and improve the lives of patients worldwide.